PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumour tissue.

por Gruis, N. A., Abeln, E. C., Bardoel, A. F., Devilee, P., Frants, R. R., Cornelisse, C. J.
Publicado 1993

Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer.

por Berns, E. M., Klijn, J. G., Smid, M., van Staveren, I. L., Gruis, N. A., Foekens, J. A.
Publicado 1995

Assessing a single SNP located at TERT/CLPTM1L multi-cancer risk region as a genetic modifier for risk of pancreatic cancer and melanoma in Dutch CDKN2A mutation carriers

por Christodoulou, E., Visser, M., Potjer, T. P., van der Stoep, N., Rodríguez-Girondo, M., van Doorn, R., Gruis, N.
Publicado 2019

Episodic Src activation in uveal melanoma revealed by kinase activity profiling

por Maat, W, Filali, M el, Mulder, A Dirks-, Luyten, G P M, Gruis, N A, Desjardins, L, Boender, P, Jager, M J, van der Velden, P A
Publicado 2009

Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS

por Zuidervaart, W, van Nieuwpoort, F, Stark, M, Dijkman, R, Packer, L, Borgstein, A-M, Pavey, S, van der Velden, P, Out, C, Jager, M J, Hayward, N K, Gruis, N A
Publicado 2005

Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development

por Zuidervaart, W, van der Velden, P A, Hurks, M H, van Nieuwpoort, F A, Out-Luiting, C J J, Singh, A D, Frants, R R, Jager, M J, Gruis, N A
Publicado 2003

GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi

por Vader, M J C, Madigan, M C, Versluis, M, Suleiman, H M, Gezgin, G, Gruis, N A, Out-Luiting, J J, Bergman, W, Verdijk, R M, Jager, M J, van der Velden, P A
Publicado 2017

MC1R gene variants and non-melanoma skin cancer: a pooled-analysis from the M-SKIP project

por Tagliabue, E, Fargnoli, M C, Gandini, S, Maisonneuve, P, Liu, F, Kayser, M, Nijsten, T, Han, J, Kumar, R, Gruis, N A, Ferrucci, L, Branicki, W, Dwyer, T, Blizzard, L, Helsing, P, Autier, P, García-Borrón, J C, Kanetsky, P A, Landi, M T, Little, J, Newton-Bishop, J, Sera, F, Raimondi, S
Publicado 2015

Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study

por Demenais, F., Mohamdi, H., Chaudru, V., Goldstein, A. M., Newton Bishop, J. A., Bishop, D. T., Kanetsky, P. A., Hayward, N. K., Gillanders, E., Elder, D. E., Avril, M. F., Azizi, E., van Belle, P., Bergman, W., Bianchi-Scarrà, G., Bressac-de Paillerets, B., Calista, D., Carrera, C., Hansson, J., Harland, M., Hogg, D., Höiom, V., Holland, E. A., Ingvar, C., Landi, M. T., Lang, J. M., Mackie, R. M., Mann, G. J., Ming, M. E., Njauw, C. J., Olsson, H., Palmer, J., Pastorino, L., Puig, S., Randerson-Moor, J., Stark, M., Tsao, H., Tucker, M. A., van der Velden, P., Yang, X. R., Gruis, N.
Publicado 2010

Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia

por Dalmasso, B., Pastorino, L., Nathan, V., Shah, N. N., Palmer, J. M., Howlie, M., Johansson, P. A., Freedman, N. D., Carter, B. D., Beane-Freeman, L., Hicks, B., Molven, A., Helgadottir, H., Sankar, A., Tsao, H., Stratigos, A. J., Helsing, P., Van Doorn, R., Gruis, N. A., Visser, M., Wadt, K. A. W., Mann, G., Holland, E. A., Nagore, E., Potrony, M., Puig, S., Menin, C., Peris, K., Fargnoli, M. C., Calista, D., Soufir, N., Harland, M., Bishop, T., Kanetsky, P. A., Elder, D. E., Andreotti, V., Vanni, I., Bruno, W., Höiom, V., Tucker, M. A., Yang, X. R., Andresen, P. A., Adams, D. J., Landi, M. T., Hayward, N. K., Goldstein, A. M., Ghiorzo, P.
Publicado 2021